Woodline Partners LP Acumen Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.81 - $10.17 $28,792 - $60,877	-5,986 Reduced 1.39%	426,172 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$4.44 - $10.48 $26,586 - $62,754	5,988 Added 1.41%	432,158 $4.34 Million
Q2 2022 Aug 15, 2022	SELL	$3.08 - $4.88 $231,203 - $366,322	-75,066 Reduced 14.98%	426,170 $2 Million
Q1 2022 May 16, 2022	BUY	$3.91 - $6.73 $80,370 - $138,335	20,555 Added 4.28%	501,236 $1.96 Million
Q4 2021 Feb 14, 2022	BUY	$6.54 - $15.31 $77,740 - $181,989	11,887 Added 2.54%	480,681 $3.25 Million
Q3 2021 Nov 15, 2021	BUY	$14.5 - $20.28 $6.8 Million - $9.51 Million	468,794 New	468,794 $6.97 Million

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $96M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.